Birmingham, AL (PRWEB) November 01, 2011
Attorneys with Cory Watson Crowder & DeGaris are representing women who have suffered injuries as a result of receiving a transvaginal mesh implant (TVM) for treatment of pelvic organ prolapse (POP) or stress urinary incontinence (SUI), according to Cory Watson attorney Jon Conlin.
Pelvic organ prolapse (POP) is a medical condition that occurs when the internal support structure of the vagina fails. During transvaginal mesh implant surgery, a synthetic mesh is inserted to help hold the woman’s internal organs such as the urethra, cervix , bladder and rectum in place. In July, 2011, the Food and Drug Administration published a report on the safety and effectiveness of transvaginal placement for pelvic organ prolapse stating that market data from manufacturers indicates that in 2010, more than 75,000 women had transvaginal mesh surgery, (TVM surgery) to repair pelvic organ prolapse. This accounted for some 75% of all POP procedures performed, according to industry and FDA estimates.
A study published in the New England Journal of Medicine in May, 2011 revealed troubling results with transvaginal mesh implant procedures, and the U.S. Food and Drug Administration (FDA) warned, “The most frequent complications included erosion through vaginal epithelium, infection, pain, urinary problems, and recurrence of prolapse and/or incontinence. There were also reports of bowel, bladder, and blood vessel perforation during insertion.”
The FDA issued an urgent safety communication in July, 2011 (" FDA Safety Communication: UPDATE on Serious Complications Associated with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse") indicating that women who have received transvaginal mesh implants have reported a number of complications including infection, pain, urinary problems, internal bleeding, vaginal scarring, pain during sexual intercourse, tissue erosion and recurrence of prolapse, incontinence or both.
The FDA communication says FDA officials met to discuss a potential ban on the mesh, after receiving more than 3,875 injury reports associated with the mesh; three of the reported cases involved fatalities.The communication advised patients and their healthcare providers to consider alternatives to transvaginal mesh (TVM).
Cory Watson Crowder & DeGaris attorneys are on record as being at the forefront of litigation involving medical devices used to treat pelvic organ prolapse and stress urinary incontinence since 1999 when the firm was one of the first firms in the country to bring these cases to trial in the Lizzy Jackson vs. Boston Scientific litigation and the successful resolution of approximately 750 cases as part of the In Re: ProtoGen Sling and Vesica System Products Liability Litigation MDL No. 1387 settlement. Attorney Ernest Cory served as Lead Plaintiffs’ Counsel in the litigation.
Cory Watson Crowder and DeGaris is a Birmingham, Alabama law firm recognized nationally for its practice areas of complex litigation including class actions, pharmaceutical drugs litigation, defective medical device litigation, products liability litigation, business and securities litigation, environmental litigation, multidistrict litigation and mass torts. The firm has an extensive practice in individual personal injury and wrongful death cases. Additional information is available at http://www.cwcd.com.
# # #